Moderna, citing need for ‘flexibility,’ seeks broad clearance of fourth COVID shot

Days after Pfizer asked U.S. regulators to authorize another booster shot for people 65 and older, Moderna has followed with a similar request for all adults, arguing an OK would “provide flexibility” to public health officials and doctors.